Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering by Abe, Satoshi et al.
RESEARCH Open Access
Localization of an hTERT repressor region on
human chromosome 3p21.3 using chromosome
engineering
Satoshi Abe
1,2, Hiromi Tanaka
2, Tomomi Notsu
3, Shin-ichi Horike
4, Chikako Fujisaki
1, Dong-Lai Qi
1, Takahito Ohhira
1,
David Gilley
2, Mitsuo Oshimura
1, Hiroyuki Kugoh
1*
Abstract
Telomerase is a ribonucleoprotein enzyme that synthesizes telomeric DNA. The reactivation of telomerase activity
by aberrant upregulation/expression of its catalytic subunit hTERT is a major pathway in human tumorigenesis.
However, regulatory mechanisms that control hTERT expression are largely unknown. Previously, we and others
have demonstrated that the introduction of human chromosome 3, via microcell-mediated chromosome transfer
(MMCT), repressed transcription of the hTERT gene. These results suggested that human chromosome 3 contains a
regulatory factor(s) involved in the repression of hTERT. To further localize this putative hTERT repressor(s), we have
developed a unique experimental approach by introducing various truncated chromosome 3 regions produced by
a novel chromosomal engineering technology into the renal cell carcinoma cell line (RCC23 cells). These cells
autonomously express ectopic hTERT (exohTERT) promoted by a retroviral LTR promoter in order to permit cellular
division after repression of endogenous hTERT. We found a telomerase repressor region located within a 7-Mb
interval on chromosome 3p21.3. These results provide important information regarding hTERT regulation and a
unique method to identify hTERT repressor elements.
Background
Telomerase is a specialized reverse transcriptase that
synthesizes telomeric DNA at the ends of most eukaryotic
chromosomes. Human telomerase is composed of an
RNA moiety (hTR) and a protein catalytic subunit
(hTERT) [1]. In humans, telomerase activity is absent or
greatly reduced in most somatic cells but present in germ
and stem cells, and highly reactivated in the majority of
human cancers [2,3]. Several reports suggest that hTERT
protein levels reflect the amount of nuclear telomerase
activity [4,5]. The hTERT gene appears to be controlled
transcriptionally, though various post-transcriptional
mechanisms have been suggested to be involved in hTERT
regulation. Several lines of evidence suggest that the regu-
lation of hTERT transcription involves both repressive and
activating transcription mechanisms [6,7]. However, the
hTERT transcriptional regulatory system is highly complex
and largely unknown. Therefore, the identification of
hTERT repressor(s) is an important step in understanding
how telomerase is controlled during development, aging
and tumorigenesis.
We previously reported that the introduction of a normal
human chromosome 3 restored cellular senescence in two
immortal renal cell carcinoma cell lines, RCC23 and KC12,
using microcell-mediated chromosome transfer (MMCT)
[8,9]. This inactivation of immortal growth by human chro-
mosome 3 transfer was attributed to the loss of telomerase
activity due to the transcriptional repression of the hTERT
gene [9,10]. This work suggested that human chromosome
3 contains a locus responsible for hTERT repression.
Here we report a unique approach using MMCT to
introduce truncated chromosome 3 regions into cells
forcibly expressing hTERT to identify an hTERT repres-
sor(s). By the transfer of each truncated human chromo-
some 3, we successfully identified a 7-Mb region within
3p21.3 containing an hTERT repressor(s). We present
this approach as a useful tool for the identification and
further analysis of hTERT repressor(s).
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Construction of donor cells with truncated human
chromosome 3 fragments
To determine genomic regions that contain hTERT
repressor gene(s), we carried out MMCT of several
truncated chromosome 3 into RCC23 renal cell carci-
noma cells. The overall strategy for this approach is
shown in Figure 1.
To successfully create various truncated chromosome
3 constructs, we developed a unique targeting vector.
A ss h o w ni nF i g u r e2 A ,t h e r ea r et h r e em a i nc o m p o -
nents of this targeting construct vector: 1) ~1 kb of
terminal telomeric repeats, 2) a puromycin resistant
gene and, 3) ~4-10 kb of homologous sequences for tar-
geting specific region of human chromosome 3. We
used chicken DT40 pre-B-cells for targeted truncation
of chromosome due to its high homologous recombina-
tion frequency. Initially, a neomycin-tagged intact
human chromosome 3 (intact #3) was transferred into
DT40 cells by MMCT (Figure 1A). Resistant DT40
microcell hybrid clones stably maintaining human chro-
mosome 3 were isolated by G418 drug selection [termed
DT40(#3)] (Figure 3A). Subsequently, we generated
three targeting vectors using different homologous
s e q u e n c e s ;1 )1 0k bf r o m3 p 2 4l o c u s ,2 )~ 4k bf r o m
3p 2 2l o c u s ,a n d3 )~ 8k bf r o m3 p 2 1 . 3l o c u s .A f t e r
transfection of targeting vectors into DT40(#3) cells by
electroporation, resistant clones were isolated by G418/
puromycin double drug selection (Figure 1A). We con-
firmed the successful recombination of targeting vectors
to human chromosome 3 by Southern blotting and
PCR analysis using twenty Sequence-Tagged-Site
(STS) markers located on the human chromosome 3
(Figure 2B). The order of STS markers and physical dis-
tance among them are based on a YAC contigs of
WIGR database, UCSC Human Genome Browser data-
base and human genome resource of the National Cen-
ter for Biotechnology Information [11-13]. We isolated
clones with truncated chromosome at 3p24 locus (DT40
(#3delp24-pter)), 3p22 locus (DT40(#3delp22-pter)) and
3p21.3 locus (DT40(#3delp21.3-pter)) by FISH analysis.
FISH analysis showed that all clones underwent targeted
truncation at the three homologous regions (green dots
in Figure 3B-C). Targeting ratio was 4 of 39 (10.36%) in
DT40(#3delp24-pter) clone, 1 of 238 (0.42%) clone
in DT40(#3delp22-pter) clone and 1 of 120 (0.83%) in
DT40(#3delp21.3-pter) clone. It is likely that recombina-
tion efficiency not only depends on the length of homo-
logous regions but also primary sequences within these
targeting homologous regions.
To increase the efficiency of chromosome transfer into
recipient cells, we transferred each truncated chromo-
some 3 into mouse A9 cells (Figure 1A). Following
MMCT, we successfully isolated A9 microcell hybrid
clones from each DT40(#3delp24-pter), DT40(#3delp22-
pter) and DT40(#3delp21.3-pter) donor cells and
each truncated human chromosome 3 was confirmed
by FISH analysis to isolate clones containing a single
truncated human chromosome [termed A9(#3delp24-
pter), A9(#3delp22-pter) and A9(#3delp21.3-pter),
respectively] (data not shown). Under drug selection in
culture condition, the truncated human chromosome
3 was retained stably in mouse A9 cells (data not
shown).
Figure 1 The mapping approach for the identification of an hTERT repressor. (A) Generation of truncated human chromosome
3 fragments was schematically shown. (B) Creation of RCC23 cells expressing ectopic hTERT by retroviral infection. An intact or truncated
chromosome 3 (#3) fragments were transferred into RCC23-exohTERT cells. See text for details.
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ectopic hTERT expression and introduction of truncated
chromosome 3 fragments
Previously, we found that the introduction of human
chromosome 3 in RCC23 cells causes telomerase repres-
sion, along with the growth arrest after 10-30 population
doublings (PDs) [10]. However, due to this severe
growth arrest after telomerase repression, it was not
possible to obtain sufficient cell numbers for functional
studies. Interestingly, several reports suggest that a
telomerase repressor located on human chromosome 3
may suppress E-box element mediated hTERT transcrip-
tion [14-16]. Therefore we established an RCC23 cell
line with autonomous expression of ectopic hTERT
(exohTERT) with a retroviral LTR promoter (termed
RCC23-exohTERT), in order to permit cellular division
after chromosome 3 transfer (Figure 1B). An additional
advantage of this retroviral vector is that exohTERT can
be distinguished from endogenous hTERT by RT-PCR
analysis using specific primer sets (Figure 4A, B). We
Figure 2 Construction of truncated chromosome 3 in DT40 cells by telomere seeding. (A) Targeting strategy of generating truncated
chromosome. (B) Summary of PCR analyses on truncated chromosomes in DT40 cells. Twenty STS markers on chromosome 3 examined were
shown. Solid circles and open circles represent presence and absence of truncated allele at tested loci in DT40 cells, respectively.
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exohTERT cells by the increase of telomerase activity
and the telomere elongation compared to RCC23 paren-
tal cell population (Figure 4C and data not shown). We
also found that long-term culture (~50 PDs) did not
change expression levels of both endogenous hTERT
and exohTERT (Figure 4D).
Using the RCC23-exohTERT cells, we first introduced an
intact human chromosome 3 via MMCT. As expected,
transferred chromosome 3 in RCC23-exohTERT cells sup-
pressed endogenous hTERT expression, nevertheless the
cells expressed exohTERT and continued to grow normally
without morphologic change (Figure 5). This result sug-
gests that ectopic exohTERT expression permits telomer-
ase activity with endogenous hTERT repression, thereby
preventing cellular senescence in these microcell hybrid
cells. To explore which truncated chromosome fragment
contains hTERT repression, three truncated chromosomes
were transferred into RCC23-exohTERT cells. We isolated
three microcell hybrid clones with truncated chromosome
(#3delp24-pter and #3delp21.3-pter) and nine microcell
hybrid clones with truncated chromosome (#3delp22-pter)
and examined the expression profiles of hTERT in each
microcell hybrid clones by RT-PCR analysis (Figure 5).
Microcell hybrids generated by the introduction of trun-
cated human chromosome 3, all RCC23-exohTERT
(#3delp24-pter) and RCC23-exohTERT(#3delp22-pter)
clones, showed complete repression of endogenous
hTERT expression. Conversely, the remaining RCC23-
exohTERT(#3delp21.3-pter) microcell hybrid clone had no
effect. These results indicate the presence of the hTERT
repressor locus on the 3p21.3-p22 region commonly
retained in truncated chromosomes #3delp24-pter and
#3delp22-pter, but not #3delp21.3-pter.
Chromosome mapping for the identification of region
containing the hTERT repression effect
To determine which region in 3p21.3-p22 carries the
telomerase repressor element, we performed PCR ana-
lysis of A9 microcell hybrid clones using a total of 24
STS markers located on the human chromosome 3
( F i g u r e1a n d6 ) .W ef o u n dt h a ts e v e nS T Sm a r k e r s
(from D3S1029 to D3S1568) were present commonly in
an intact chromosome 3, two truncated chromosomes
#3delp24-pter and #3delp22-pter which had hTERT
repression effect (Figure 5 and 6). However truncated
chromosome #3delp21.3-pter which had no effect on
the hTERT expression lost these seven markers (Figure
5 and 6). Thus, these results indicate that 7-Mb interval
between D3S3597 and D3S1573 on 3p21.3 contains the
region that significantly affect repression of hTERT
expression, suggesting that this minimal region controls
telomerase activity through suppression of hTERT
expression in RCC23 cells.
Discussion
We have previously shown that the introduction of
human chromosome 3 suppresses telomerase activity
due to the repression of the hTERT transcription. Here,
we report that the result of the fine mapping of a telo-
merase repressor gene within the human chromosome
3p21.3 region by functional analysis of various truncated
chromosome 3 fragments.
To further isolate the telomerase repressor region(s) on
chromosome 3, we utilized MMCT using several trun-
cated chromosome 3 in RCC23-exohTERT cells. Unlike
X-irradiated chromosome transfer method [17] or deletion
mapping [18], this targeted truncation technique allows
the removal of specific regions on a targeted chromosome
Figure 3 FISH analysis of truncated human chromosome 3 in DT40 cells. Upper panels show representative metaphase spreads (A-D) and
bottom panels show the enlarge image of human chromosome with allow. The allow shows a targeting site on chromosome 3 using biotin-
labeled PGK-puro probe (green color). (A) DT40 containing an intact human chromosome 3. (B) DT40 containing #3delp24-pter. (C) DT40
containing #3delp22-pter. (D) DT40 containing #3delp21.3-pter. Digoxigenin-labeled human COT-1 probe (red color) indicates human
chromosome. DAPI staining (blue color) shows chicken chromosomes.
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DT40 cells are able to facilitate truncation efficiency of
chromosome at desired sites [19-21]. Indeed, we could
truncate chromosome with the high targeting efficiency at
least forty-fold using DT40 cells compared to <0.01% with
conventional methods [22].
Gene functional analysis by MMCT from mouse A9/
human monochromosomal hybrids to suitable recipient
cells, has been utilize to map responsible genes involved in
cellular aging, metastasis, DNA repair and tumor suppres-
sion [23]. Because the repression of hTERT transcription
results in the induction of cellular senescence it was not
possible to obtain sufficient cell numbers for functional
studies. In this study, RCC23-exohTERT cells ectopically
expressing exohTERT with a viral LTR promoter enable us
to study endogenous hTERT repression by preventing cel-
lular senescence. Thus, RCC23-exohTERT cells will serve
as a valuable resource for the mapping and identification
of genes that function during cellular aging involving telo-
merase regulation.
Using MMCT, we have shown that the introduction of
either chromosome 3 or 10 and truncated chromosome
3 results in the complete repression of hTERT transcrip-
tion in human tumor cells [8,24], suggesting that there
are multiple telomerase-dependent pathways for the reg-
ulation of cellular senescence [25]. However, human/
mouse A9 monochromosomal hybrids that carry these
human chromosomes used as donor were all positive for
Figure 4 Generation and characteristics of RCC23 cells expressing ectopic hTERT (A) Distinct PCR primer design between endogenous and
exogenous hTERT genes. Native UTR sequence was shown in gray rectangle. Additional sequences only in exogenous hTERT cDNA were shown in
dark rectangle. Solid allow heads, primers for endogenous hTERT. Open allow heads, primers for endogenous hTERT. (B) Detection of ectopic
hTERT expression in RCC23-exohTERT cells. RT-PCR was performed with (+) or without (-) reverse transcriptase (RT). endohTERT, endogenous hTERT.
exohTERT, exogenous hTERT. (C) Upregulation of telomerase activity in RCC23-exohTERT cells. Enzymatic activity was heat-inactivated for a
negative control. (D) Maintenance of exohTERT expression in RCC23-exohTERT cells during long-term culture. RCC23-exohTERT cells were cultured
in the presence or absence of hygromycine B (Hyg, drug resistant marker of retroviral vector) until 25 PDs or 50 PDs and RT-PCR was performed
for hTERT expression.
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this phenomenon was caused by some significant differ-
ences between human and mouse biology. Specifically,
telomeres in inbred mouse strains are on average much
longer than those in humans. Moreover, the expression
of hTERT is more tightly regulated than that of mtert in
normal somatic cells, although the expression of both
genes is strongly up-regulated in mouse or human
tumors.
Tanaka et al. (2005) previously reported that a renal
cell carcinoma cell line, KC12 shared the same genetic
defect of telomerase repressor function as the RCC23
cell line using a genetic complementation approach [26].
Remarkably, the candidate region that was found using
deletion mapping of KC12 revertant clones that escaped
from cellular senescence overlapped with the region
identified in this report [26]. When we identified the tel-
omerase repressor gene(s) within this candidate region
using the functional analysis of truncated chromosomal
regions within this study, it confirmed the effect of
hTERT suppression found in KC12 cells. In addition, we
did not check the effect of chromosome 3 for expression
of hTERT in other type of human cells. However, it has
been reported that genomic abnormalities in the chro-
mosome 3p and 3p21 region are present in various
types of human cancers [27]. Therefore, identification of
a telomerase repressor gene(s) within this region should
facilitate our understanding of the molecular mechan-
isms that are involved in cancer development.
Consistent with previous reports, we identified a can-
didate region that contains a telomerase repressor ele-
ment on chromosome 3p21.3 within a 7-Mb region
[26]. Conversely, Szutorisz et al. (2003) mapped another
hTERT repressor gene of a breast carcinoma cell line
21NT at a distinct locus on chromosome 3p [28]. Taken
together, we have evidence that renal cell carcinoma
(RCC23 and KC12) and breast carcinoma (21NT) have
different defects in telomerase repression. This impli-
cates that there are at least two telomerase repressors
on human chromosome 3p and the tissue-specific regu-
lation of telomerase might be involved during human
development and carcinogenesis [26].
Renal cell carcinoma shows frequent deletion of the
short-arm of human chromosome 3 [27,29]. The candi-
date region on 3p21.3 harbors various tumor suppressor
genes (HYAL2, FUS1, RASSF1, BLU, NPR2L, CYB561D2,
PL6 and CACNA2D2). It is unlikely that RASSF1A is an
hTERT repressor gene on chromosome 3p21.3 because
the forced expression of RASSF1 in RCC23 cells did not
repress hTERT promoter activity [26]. Other candidate
genes on 3p21.3 will need to be analyzed. Additionally,
novel microRNAs on 3p21.3 may potentially affect tran-
scriptional regulation of hTERT, since numerous micro-
RNAs have recently been shown as regulatory factors
for tumor suppression [30]. In fact, it was reported that
overexpression of miR-138 (mapped to 3p21) downregu-
lated hTERT protein level but not hTERT mRNA in
human thyroid carcinoma cell lines. It is thus unlikely
that the miR-138 functions as a transcriptional repressor
of hTERT [31]. Taken together, human chromosome 3
may harbor multiple telomerase regulating factors that
act in a tissue-specific manner or through different
pathways such as telomerase inactivation with or with-
out hTERT transcriptional repression.
Figure 5 hTERT repression effect on #3delp24-pter and #3del22-pter, but not #3delp21.3-pter T w oc l o n e so fe a c hR C C 2 3 - exohTERT
microcell hybrids were examined by RT-PCR. GAPDH was used as an internal control. RT-PCR was performed with (+) or without (-) reverse
transcriptase (RT). Note that the RCC23-exohTERT microcell hybrid containing an intact (#3) or the truncated human chromosome 3, #3delp24-
pter or #3delp22-pter has no expression of endogenous hTERT gene (endohTERT).
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chromosomal engineering technique is expected to facil-
itate the positional cloning of the telomerase repressor
by a series of cutting down the 7-Mb region and trap
the telomerase repressor locus in YAC (Yeast Artificial
Chromosome) or BAC/PAC (Bacterial Artificial Chro-
mosome/P1-derived Artificial Chromosome) clones.
Furthermore, our group previously reported the con-
struction of a human artificial chromosome (HAC)
vector that has the capability to clone extremely large
genomic regions and a utility for potential gene thera-
peutic uses [32]. The HAC vector is maintained inde-
pendently in cells without genomic integration because
it contains autonomous elements such as telomeres,
centromeres and replication origins [33]. The combina-
tion of the HAC vector and human genome BAC/PAC
l i b r a r i e sw i l lb eau s e f u lf u n c t i o n a la n a l y s i sa p p r o a c ht o
evaluate a cluster of genes [34]. Additionally, positional
Figure 6 Identification of an hTERT repressor locus on human chromosome 3p21.3 Twenty-four STS markers on 3p examined were shown.
Open circles, absence of tested loci in transferred human chromosome. Closed circles, presence of tested loci in transferred human chromosome.
STS markers in bold were used in Figure 2b as well. Note that 7-Mb interval between D3S3597 and D3S1573 on 3p21.3 contains the effect of
endogenous hTERT repression into RCC23-exohTERT cells. Interstitial deletion of transferred chromosome was observed on D3S1573 and D3S3561
loci in A9(#3delp2-pter) clone, and D3S1573 locus in A9(#3del21.3-pter) clone.
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allows direct cloning of a specific chromosomal region
from the human genome using in vivo recombination in
yeast [35,36]. The precise mapping information of candi-
date genes to a defined region of a human chromosome
will provide the necessary information for isolation of
telomerase repressor genes and help lead to mechanistic
understanding of the control of hTERT transcription.
Materials and methods
Cell culture
Chicken DT40 cells containing chromosome 3 were main-
tained in RPMI-1640 (Invitrogen, Carlsbad, CA) with 10%
fetal bovine serum (JRH Biosciences, Lenexa, KS), 1%
chicken serum (Invitrogen), 50 μM 2-mercaptoethanol
(Sigma), 1.5 mg/ml G418 (Invitrogen) and the appropriate
antibiotics. DT40 hybrid cells containing truncated chro-
mosomes were selected with 1.5 mg/ml G418 and 0.3 μg/
ml puromycin (Sigma). A9 hybrid cells carrying intact or
truncated chromosomes were selected with 800 μg/ml
G418. Human renal cell carcinoma cell line RCC23 was
maintained in RPMI-1640 supplemented with 10% FBS.
Microcell-mediated chromosome transfer
MMCT was performed to introduce truncated human
chromosomes from DT40 to A9 cells as described pre-
v i o u s l y[ 3 3 ] .B r i e f l y ,1×1 0
9 microcells were prepared
by centrifuge in coating flasks (Nalge Nunc, Rochester,
NY) with poly-L-lysine (Sigma) and were fused to A9
cells by 47% polyethylene glycol 1000 (WAKO, Japan).
Chromosome transfer into RCC23-exohTERT cells was
performed using standard procedures [37]. A9 hybrid
clones were treated with 0.05 μg/ml of colcemid to
induce the formation of micronuclei, which were then
purified by 10 μg/ml cytochalasin B (Sigma) digestion
and centrifugation. After centrifugation, the isolated
microcells were resuspended in serum-free DMEM and
filtered sequentially through 8-, 5-, and 3-μm polycarbo-
nate filter (Whatman). The purified microcells were col-
lected by centrifugation at 400 × g for 15 min and
resuspended in serum-free DMEM containing 50 μg/ml
of phytohemagglutinin-P (Wako). The microcells were
attached to monolayer cells at 37°C for 15 min. The
microcells were fused with recipient cells in a 47% PEG
solution for 1 min, followed by extensive washing with
serum-free DMEM. The cells were maintained in non-
selective medium for 24 hr, then trypsinized and split
into three 100-mm dishes containing selection medium.
Generation of DT40 cells with truncated human
chromosome 3
For chromosome truncation at 3p24 locus, cosmid cCI3-
1202 was obtained from Japanese Collection of Research
Bioresources (JCRB) for construction of a targeting vec-
tor. 10 kb of EcoRI-digested DNA form cCI3-1202 was
used as a homologous sequence. For chromosome trun-
cation at 3p22 and 3p21.3 loci, cosminds c305 and
Z84494 were used as a PCR template to amplify the
homologous region. The following primer sets were
used for PCR; 5′-ATG GAT CCA ACA CAC ACC ACC
CTC ATG TAT GTC CA-3′ and 5′-ATG GAT CCC
AGA CCA AGT CCG GAA GAG CTG CTT-3′ for
3p22 homologous region, 5′-ATC CCT GGC CTG TCA
CCA CT-3′ and 5′-GGC CTG ACA GCA GCA CAT
TT-3′ for 3p21.3 homologous region. The PCR product
was cloned into BamHI-digested pBS-TEL/Puro vector
[22] by ligation. Targeting constructs which contain
telomeric repeats, puromycin resistant gene and homo-
logous sequence were linearized and transfected by elec-
troporation under condition at 550 V and 25 μFi n t o
DT40 cells carrying a human chromosome 3 as
described previously [33]. The cells were resuspended in
basic growth medium and aliquoted into four 96-well
plates. After 2 days, the cells were resuspended in selec-
tive medium with puromycin. After 2 week, drug resis-
tant colonies were isolated and expanded for subsequent
analyses. The recombination was confirmed by Southern
blotting or PCR.
Generation of RCC23 cells expressing ectopic hTERT
Retroviral protein expression vector, pBABE(hyg)-
hTERT was used for introduction of ectopic hTERT
gene (exohTERT) into RCC23 cells. The construct is a
kind gift from Dr. Collins (UC Berkeley, USA) [38].
Viral supernatant was generated by stable transfection
of a packaging cell line (PT67, Clontech). RCC23 cells
were seeded at 2 × 10
5 cells per 60 mm dish at 1 day
before infection. For infection, the culture medium was
replaced by viral supernatant everyday for three days.
After overnight of the third infection, the infected cells
were selected by culture in 200 μg/ml hygromycin B.
RNA isolation and RT-PCR for hTERT expression
Total RNA was extracted by using RNeasy mini kit
(Qiagen) and treated with DNase I (Wako). The first-
strand cDNA was synthesized using M-MLV reverse
transcriptase (Invitrogen) with the oligo(dT)15
primer. cDNA was amplified using 5′-CGA GAG CAG
A C AC C AG C AG - 3 ′ and 5′-TTTTACTCCCACAG-
CACCTC-3′ for endogenous hTERT;5 ′-GAC GAC
GAT GAC AAG GGA AT-3′ and 5′-AGC ACC TCG
CGG TAG TGG-3′ for exogenous hTERT;5 ′-CCA TCT
T C CA G GA G CG A GA - 3 ′ and 5′-TGT CAT ACC
AGG AAA TGA GC-3′ for GAPDH. The PCR reaction
for endogenous hTERT was performed using Advan-
tage2 PCR kit (Clontech).
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The presence or absence of the region on human chro-
mosome 3 was checked by PCR using 24 specific
sequence-tagged site (STS) markers (D3S1560, D3S1304,
D3S1317, D3S1038, D3S1266, D3S1283, D3S647,
D3S1100, D3S1029, D3S1478, D3S1289, D3S1300,
D3S1312, D3S1600, D3S1285, D3S1284, D3S1278,
D3S1238, D3S1237, D3S1314, D3S3547, D3S1561,
D3S1298, D3S1260, D3S3521, D3S3658, D3S3563,
D3S3597, D3S3624, D3S3582, D3S3629, D3S3667,
D3S1568, D3S1573, D3S3561, D3S1578, D3S3672). Pri-
mer information was obtained from NCBI database [11].
PCR was processed through 35 cycles of PCR consisting
of 30 sec at 94°C, 30 sec at 58-62°C and 30 sec at 72°C.
FISH analysis
FISH analysis was performed using fixed metaphase
spreads of each DT40 cells carrying intact or truncated
chromosomes and the combination with digoxigenin-
labeled (Roche, Basel, Switzerland) human COT-1 DNA
(Invitrogen) and biotin-labeled PGK-puro plasmid DNA
as described previously [39]. For metaphase of each A9
hybrid carrying intact or truncated chromosomes, digox-
igenin-labeled human COT-1 DNA was used for the
detection of the human chromosome. Chromosomal
DNA was counterstained with DAPI (Sigma). The
images were captured using the Argus system (Hama-
matsu Photonics, Hamamatsu, Japan).
Telomerase activity assay
Telomerase activity was measured by TeloChaser
(TOYOBO, Japan) according to the manufacturer’s pro-
tocol. The reaction products were electrophoresed on a
12.5% nondenaturing polyacrylamide gel and visualized
by SYBR GREEN I staining (Invitrogen).
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